NCT06190431

Brief Summary

The use of mechanical insufflation-exsufflation (MI-E) in children with neuromuscular diseases (NMD) is recommended by international guidelines and societies and well documented. Many authors have shown that MI-E is safe and effective for airway clearance and has a significant benefit in reducing the duration of the airway clearance session in children with respiratory infections and atelectasis or in the postoperative period. However, its use in paediatrics is still poorly supervised and learning the technique is too often therapist- and/or patient-dependent. The use of a protocol or means of help to guide the initiation and learning of MI-E would allow better use, better adaptation of the settings and potentially better compliance with the treatment. The aim of this study is to test whether the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the technique compared to guidance alone.This randomized controlled study will first include healthy children, aged 6 to 12 years, with no history or recent respiratory infection affecting lung function or other chronic diseases. In a second phase, the investigators will test the use of the learning process in children with neuromuscular diseases. The investigators hope that the results of this study will provide a better framework for the learning and effectiveness of MI-E. Furthermore, if the results are positive, this will allow better support for the use of MI-E in chronic treatments and help to ensure that this costly treatment for hospitals and public health is used efficiently.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2023

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

December 8, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2024

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 5, 2024

Status Verified

December 1, 2023

Enrollment Period

2 months

First QC Date

December 8, 2023

Last Update Submit

January 3, 2024

Conditions

Keywords

Mechanical In-ExsufflationCoachingCough AssistancePediatric

Outcome Measures

Primary Outcomes (2)

  • Effectiveness

    The investigators will measure the number of sets (n) needed by the subjects to achieve five quality voluntary coughs during the learning session.

    A the end of the learning session (after maximum 15 minutes)

  • Effectiveness

    The investigators will measure the time needed (sec) by the subjects to achieve five quality voluntary coughs during the learning session.

    A the end of the learning (after maximum 15 minutes).

Secondary Outcomes (8)

  • Peak cough flow measured with the device (L/min)

    During the learning session (max 15 minutes)

  • Peak cough flow measured with the device (L/min)

    During the session on the second day (24 hours after the learning session)

  • Visual analog scales (VAS) "ease of use" (0-10)

    At the end of the learning session (max 15 minutes)

  • Visual analog scales (VAS) "ease of use" (0-10)

    At the end of the session on the second day (24 hours after the learning session)

  • Visual analog scales (VAS) "comfort" (0-10)

    At the end of the learning session (max 15 minutes)

  • +3 more secondary outcomes

Study Arms (2)

Only physiotherapist guidance

ACTIVE COMPARATOR

The aim of this study is to test whether the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the technique compared to guidance alone.

Other: Learning the use of an in-exsufflation device with the guidance of a physiotherapist

Physiotherapist guidance + coaching module

ACTIVE COMPARATOR

The aim of this study is to test whether the use of a coaching module (playful visual stimulation) in addition to guidance by a physiotherapist improves the learning and effectiveness of the technique compared to guidance alone.

Other: Learning the use of an in-exsufflation device with the guidance of a physiotherapistOther: Using the coaching mode

Interventions

Learning to use an in-exsufflation device with the guidance of a physiotherapist

Only physiotherapist guidancePhysiotherapist guidance + coaching module

Learning the use of an in-exsufflation device using a coaching mode (playful visual stimulation) in addition to guidance of a physiotherapist

Physiotherapist guidance + coaching module

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age 6-12 (F/M)
  • Acceptance of consent (child + 2 parents)
  • Non-smoker
  • Speak and understand French
  • Schooling in mainstream education

You may not qualify if:

  • Comorbidities: congenital heart disease, chronic lung disease, immune deficiency, neuromuscular disease, neurological disease or multiple disabilities
  • History or clinical signs of disease affecting lung function, recent lung infection, spinal or thoracic deformity.
  • Part 2:
  • Age 6-12 (F/M)
  • Acceptance of consent (child + 2 parents)
  • Non-smoker
  • Speak and understand French
  • Patient with a neuromuscular disease
  • Able to perform the MI-E maneuver
  • Hemodynamic instability
  • Current or recent pneumothorax
  • Hemoptysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cliniques universitaires Saint Luc

Brussels, 1200, Belgium

RECRUITING

Related Publications (5)

  • Panitch HB. Respiratory Implications of Pediatric Neuromuscular Disease. Respir Care. 2017 Jun;62(6):826-848. doi: 10.4187/respcare.05250.

    PMID: 28546380BACKGROUND
  • Miske LJ, McDonough JM, Weiner DJ, Panitch HB. Changes in gastric pressure and volume during mechanical in-exsufflation. Pediatr Pulmonol. 2013 Aug;48(8):824-9. doi: 10.1002/ppul.22671. Epub 2012 Sep 4.

    PMID: 22949331BACKGROUND
  • Hov B, Andersen T, Toussaint M, Mikalsen IB, Vollsaeter M, Markussen H, Indrekvam S, Hovland V. User-perceived impact of long-term mechanical assisted cough in paediatric neurodisability. Dev Med Child Neurol. 2023 May;65(5):655-663. doi: 10.1111/dmcn.15543. Epub 2023 Feb 14.

    PMID: 36787316BACKGROUND
  • Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J, Gibson N, Gordon J, Hughes I, McCulloch R, Russell RR, Simonds A. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax. 2012 Jul;67 Suppl 1:i1-40. doi: 10.1136/thoraxjnl-2012-201964. No abstract available.

    PMID: 22730428BACKGROUND
  • Hov B, Andersen T, Toussaint M, Vollsaeter M, Mikalsen IB, Indrekvam S, Hovland V. Prevalence of long-term mechanical insufflation-exsufflation in children with neurological conditions: a population-based study. Dev Med Child Neurol. 2021 May;63(5):537-544. doi: 10.1111/dmcn.14797. Epub 2021 Jan 3.

    PMID: 33393110BACKGROUND

MeSH Terms

Conditions

CoughNeuromuscular Diseases

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsNervous System Diseases

Study Officials

  • Nicolas Audag, PhD

    Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2023

First Posted

January 5, 2024

Study Start

November 20, 2023

Primary Completion

January 20, 2024

Study Completion

December 31, 2024

Last Updated

January 5, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations